Studies have shown that knockout of SLC38A1 significantly inhibits HCC cell growth and migration, and that SLC38A1 regulates the occurrence and progression of HCC through glutamine-mediated energy metabolism by modulating the PI3K/AKT/mTOR signaling pathway (Hg et al., 2023). The gene discussed is AKT1; the disease is hepatocellular carcinoma.